House Dems host “The Things We’ll Never Know: A Science Fair of Canceled Grants”

GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise

Bits of good news for NIH flickered consistently over the past week.

August 01, 2025

City of Hope brings evidence-based approaches to integrative oncology

The landscape of cancer care is evolving rapidly, with growing recognition that optimal patient outcomes require a whole-person care approach that goes beyond cytotoxic and targeted therapies.

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

A report from the nonpartisan Congressional Budget Office said that proposed cuts at NIH could lead to a decrease in the number of new drugs that come to market in the next three decades.

Six researchers awarded $5.3M for pancreatic cancer research by Stephenson Global

The Stephenson Global Pancreatic Cancer Research Institute and its partner, City of Hope, announced the six inaugural recipients of the Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, early detection, and treatment of pancreatic cancer (The Cancer Letter, Sept. 17, 2024).

July 25, 2025

Vol.51 No.29

In Brief

Dispatch Bio aims to deliver universal treatment across solid tumors with novel immunotherapy approach

Dispatch Bio, a company aiming to engineer a universal immunotherapy treatment across solid tumors, announced its official launch.

July 25, 2025

Vol.51 No.29

In Brief

Geraldine O’Sullivan Coyne to lead early-stage clinical trials at Northwell’s START Center for Cancer Research

Geraldine O’Sullivan Coyne was appointed system head of Northwell and principal investigator for the START Center for Cancer Research, a newly established unit at the health system aimed at bringing innovative early stage clinical trials to patients in a community-based cancer center.

July 25, 2025

Vol.51 No.29

House Dems host “The Things We’ll Never Know: A Science Fair of Canceled Grants”

YOU MAY BE INTERESTED IN

GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise

City of Hope brings evidence-based approaches to integrative oncology

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

Six researchers awarded $5.3M for pancreatic cancer research by Stephenson Global

Dispatch Bio aims to deliver universal treatment across solid tumors with novel immunotherapy approach

Geraldine O’Sullivan Coyne to lead early-stage clinical trials at Northwell’s START Center for Cancer Research

Renew today!

Subscriber content

Never miss an issue!

Login

House Dems host “The Things We’ll Never Know: A Science Fair of Canceled Grants”

YOU MAY BE INTERESTED IN

GOP-led Congress rejects Trump’s plans to gut medical researchSenate bill gives NIH a $400 million raise

City of Hope brings evidence-based approaches to integrative oncology

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

Six researchers awarded $5.3M for pancreatic cancer research by Stephenson Global

Dispatch Bio aims to deliver universal treatment across solid tumors with novel immunotherapy approach

Geraldine O’Sullivan Coyne to lead early-stage clinical trials at Northwell’s START Center for Cancer Research

Never miss an issue!

Login

GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise